Andra Ap Fonden Alkermes Plc. Transaction History

Andra Ap Fonden

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 10, 2020	SELL	$17.29 - $21.74 $1.58 Million - $1.98 Million	-91,200 Closed	0 $0
Q3 2019 Nov 19, 2019	BUY	$19.51 - $24.28 $81,942 - $101,976	4,200 Added 4.83%	91,200 $1.78 Million
Q2 2019 Aug 15, 2019	BUY	$21.47 - $37.33 $1.1 Million - $1.92 Million	51,300 Added 143.7%	87,000 $1.96 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $698,640 - $897,654	24,600 Added 221.62%	35,700 $1.3 Million
Q3 2018 Oct 16, 2018	SELL	$38.6 - $46.12 $1.08 Million - $1.29 Million	-27,900 Reduced 71.54%	11,100 $471,000
Q2 2018 Aug 17, 2018	SELL	$40.56 - $51.36 $401,544 - $508,464	-9,900 Reduced 20.25%	39,000 $1.61 Million
Q1 2018 Apr 10, 2018	BUY	$53.61 - $67.26 $2.05 Million - $2.57 Million	38,200 Added 357.01%	48,900 $2.83 Million
Q3 2017 Oct 31, 2017	BUY	$49.16 - $54.45 $526,012 - $582,615	10,700	10,700 $544,000

375

166M

231K

158K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.42B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.